Biopeptek Pharmaceuticals

Biopeptek Pharmaceuticals is a private, revenue-generating peptide CDMO headquartered in Malvern, Pennsylvania. The company leverages over 40 years of collective scientific expertise to offer end-to-end peptide services, including custom synthesis, process development, analytical testing, and cGMP manufacturing up to multi-kilogram batch scales. Its business model is service-based, catering to biotech and pharmaceutical companies developing peptide-based drugs across various therapeutic areas. Biopeptek's strategy is centered on being a integrated partner for peptide drug development and commercialization.

Integrated peptide CDMO platform offering expertise in SPPS, LPPS, ligation, and fragment condensation synthesis; scale-up from research to multi-kilogram cGMP API manufacturing; dedicated analytical development; and sterile injectable drug product formulation.

Operates in a competitive peptide CDMO market with competitors ranging from large, diversified CMOs (e.g., Lonza, Bachem, PolyPeptide) to smaller, niche peptide specialists and lower-cost manufacturers in Asia. Differentiation is based on technical expertise, integrated service offering, quality, and reliability.